Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia

In this analysis, we identified febrile cancer patients with documented infections or neutropenia, whose procalcitonin levels are low at baseline or decrease on antibiotics. These patients had similar outcomes in terms of mortality and relapse of infection regardless of the duration of antimicrobial...

Descripción completa

Detalles Bibliográficos
Autores principales: Haddad, Hanine El, Chaftari, Anne-Marie, Hachem, Ray, Michael, Majd, Jiang, Ying, Yousif, Ammar, Raad, Sammy, Jordan, Mary, Chaftari, Patrick, Raad, Issam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773566/
https://www.ncbi.nlm.nih.gov/pubmed/29348438
http://dx.doi.org/10.1038/s41598-018-19616-3
_version_ 1783293586925682688
author Haddad, Hanine El
Chaftari, Anne-Marie
Hachem, Ray
Michael, Majd
Jiang, Ying
Yousif, Ammar
Raad, Sammy
Jordan, Mary
Chaftari, Patrick
Raad, Issam
author_facet Haddad, Hanine El
Chaftari, Anne-Marie
Hachem, Ray
Michael, Majd
Jiang, Ying
Yousif, Ammar
Raad, Sammy
Jordan, Mary
Chaftari, Patrick
Raad, Issam
author_sort Haddad, Hanine El
collection PubMed
description In this analysis, we identified febrile cancer patients with documented infections or neutropenia, whose procalcitonin levels are low at baseline or decrease on antibiotics. These patients had similar outcomes in terms of mortality and relapse of infection regardless of the duration of antimicrobial therapy (less or more than 7 days).
format Online
Article
Text
id pubmed-5773566
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-57735662018-01-26 Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia Haddad, Hanine El Chaftari, Anne-Marie Hachem, Ray Michael, Majd Jiang, Ying Yousif, Ammar Raad, Sammy Jordan, Mary Chaftari, Patrick Raad, Issam Sci Rep Article In this analysis, we identified febrile cancer patients with documented infections or neutropenia, whose procalcitonin levels are low at baseline or decrease on antibiotics. These patients had similar outcomes in terms of mortality and relapse of infection regardless of the duration of antimicrobial therapy (less or more than 7 days). Nature Publishing Group UK 2018-01-18 /pmc/articles/PMC5773566/ /pubmed/29348438 http://dx.doi.org/10.1038/s41598-018-19616-3 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Haddad, Hanine El
Chaftari, Anne-Marie
Hachem, Ray
Michael, Majd
Jiang, Ying
Yousif, Ammar
Raad, Sammy
Jordan, Mary
Chaftari, Patrick
Raad, Issam
Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia
title Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia
title_full Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia
title_fullStr Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia
title_full_unstemmed Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia
title_short Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia
title_sort procalcitonin guiding antimicrobial therapy duration in febrile cancer patients with documented infection or neutropenia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773566/
https://www.ncbi.nlm.nih.gov/pubmed/29348438
http://dx.doi.org/10.1038/s41598-018-19616-3
work_keys_str_mv AT haddadhanineel procalcitoninguidingantimicrobialtherapydurationinfebrilecancerpatientswithdocumentedinfectionorneutropenia
AT chaftariannemarie procalcitoninguidingantimicrobialtherapydurationinfebrilecancerpatientswithdocumentedinfectionorneutropenia
AT hachemray procalcitoninguidingantimicrobialtherapydurationinfebrilecancerpatientswithdocumentedinfectionorneutropenia
AT michaelmajd procalcitoninguidingantimicrobialtherapydurationinfebrilecancerpatientswithdocumentedinfectionorneutropenia
AT jiangying procalcitoninguidingantimicrobialtherapydurationinfebrilecancerpatientswithdocumentedinfectionorneutropenia
AT yousifammar procalcitoninguidingantimicrobialtherapydurationinfebrilecancerpatientswithdocumentedinfectionorneutropenia
AT raadsammy procalcitoninguidingantimicrobialtherapydurationinfebrilecancerpatientswithdocumentedinfectionorneutropenia
AT jordanmary procalcitoninguidingantimicrobialtherapydurationinfebrilecancerpatientswithdocumentedinfectionorneutropenia
AT chaftaripatrick procalcitoninguidingantimicrobialtherapydurationinfebrilecancerpatientswithdocumentedinfectionorneutropenia
AT raadissam procalcitoninguidingantimicrobialtherapydurationinfebrilecancerpatientswithdocumentedinfectionorneutropenia

Ejemplares similares